Results 171 to 180 of about 6,313 (203)
Some of the next articles are maybe not open access.
ā¼Insulin degludec for diabetes mellitus
Drug and Therapeutics Bulletin, 2013Over the last few years there has been a steady increase in the number of prescriptions dispensed in primary care for intermediate and long-acting insulin analogues and a reduction in prescriptions for biphasic isophane insulin. For example, in England, the volume of intermediate and long-acting insulin analogues in general practice has risen from ...
openaire +2 more sources
Insulin degludec + liraglutide: a complementary combination
Expert Opinion on Biological Therapy, 2016The treatment of patients with type 2 diabetes mellitus remains challenging, as it goes beyond adequate glycemic control, in particular addressing weight, blood pressure and other contributors to cardiovascular disease. In addition, the progressive nature of type 2 diabetes mellitus demands the intensification and combination of glucose lowering ...
K, Stinkens, B, Peene, C, Mathieu
openaire +2 more sources
Insulin degludec bei speziellen Patientengruppen
Diabetologie und Stoffwechsel, 2015Insulin degludec (IDeg) ist ein Basalinsulin mit einem stabilen, flachen Wirkprofil und einer gleichmasigen Verteilung des blutzuckersenkenden Effekts uber 24 Stunden. Mit der arzneimittelrechtlichen Zulassung stellen sich Fragen zur klinisch-praktischen Anwendung bei speziellenĀ Patientengruppen.
A. Bahrmann, B. Wilhelm, A. Zeyfang
openaire +1 more source